Netherlands-based Triple Bio has emerged from stealth with €1.5 million in funding for its RumeNRG lipid platform. The technology aims to enhance methane inhibitors and re-direct rumen hydrogen, potentially boosting milk yields by 5-10% per cow and reducing the required dose of a known inhibitor by 500-fold.
The RumeNRG platform consists of two formulations. One acts as a delivery system for existing methane inhibitors like bromoform, encapsulating active ingredients for protection and gradual release. The other, RumeNRG-Mx1, is a standalone system designed to influence hydrogen flow within the rumen, improving feed efficiency.
Founded by Paris-based climate tech venture studio Marble, Triple Bio brings together a team with expertise from companies like Mootral and Deep Branch. The lipid-based tech mimics methanogen cell membranes, a strategic approach to reduce potent greenhouse gas emissions and enhance dairy productivity.
In the near term, Triple Bio focuses on improving existing methane inhibitors through encapsulation. Longer term, the company aims for RumeNRG-Mx1 to also achieve methane reduction, alongside its current productivity benefits for dairy cows, by influencing hydrogen distribution in the rumen.
Source: AgFunderNews